Anti-S1 and S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2
Description
Antibodies capable of neutralising SARS-CoV-2 are well studied, but Fc receptor-dependent antibody activities that can also significantly impact the course of infection have not been studied in such depth. As most SARS-CoV-2 vaccines induce only anti
